HCW Biologics Inc HCWB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/17/24 EDT
1.10UNCH (UNCH)
Volume
20,538
52 week range
0.91 - 2.32
Loading...
  • Open1.10
  • Day High1.16
  • Day Low1.10
  • Prev Close1.10
  • 52 Week High2.32
  • 52 Week High Date07/20/23
  • 52 Week Low0.91
  • 52 Week Low Date11/15/23

Key Stats

  • Market Cap41.606M
  • Shares Out37.82M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-10.2

KEY STATS

  • Open1.10
  • Day High1.16
  • Day Low1.10
  • Prev Close1.10
  • 52 Week High2.32
  • 52 Week High Date07/20/23
  • 52 Week Low0.91
  • 52 Week Low Date11/15/23
  • Market Cap41.606M
  • Shares Out37.82M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-10.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.70
  • P/E (TTM)-1.58
  • Fwd P/E (NTM)-7.86
  • EBITDA (TTM)-24.582M
  • ROE (TTM)-98.23%
  • Revenue (TTM)2.842M
  • Gross Margin (TTM)19.72%
  • Net Margin (TTM)-879.53%
  • Debt To Equity (MRQ)46.83%

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On HCW Biologics Inc

 

Profile

MORE
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to...
Scott Garrett
Independent Chairman of the Board
Hing Wong Ph.D.
Chief Executive Officer, Founder, Director
Rebecca Byam
Chief Financial Officer
Address
2929 N Commerce Pkwy, Miramar, Fl 33025
Miramar, FL
33025
United States

Top Peers

SYMBOLLASTCHG%CHG
DYAI
Dyadic International Inc
1.65-0.01-0.60%
SABS
SAB Biotherapeutics Inc
3.63-0.24-6.20%
OCX
OncoCyte Corp
2.93-0.14-4.56%
OMIC
Singular Genomics Systems Inc
0.3811+0.0101+2.7224%
UNCY
Unicycive Therapeutics Inc
1.04+0.01+0.97%